TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma
Clinical trial NCT07639879 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07639879
- Sponsor
- Tarapeutics Science Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2029-07-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.